{"transactions":[{"id":4628974,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-02T21:50:48.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":26700,"derivative":{"exercise_price":1.6,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001584759-26-000017","document":"form4-10022026_091044.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000158475926000017/form4-10022026_091044.xml","form_type":"4"}},{"id":4628973,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-02T21:50:48.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":3200,"price":12.9141,"value":41325.12,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares."}],"balance_after":203472,"source":{"system":"sec-edgar","filing":"0001584759-26-000017","document":"form4-10022026_091044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000158475926000017/form4-10022026_091044.xml","form_type":"4"}},{"id":4628972,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-02T21:50:48.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":12.9141,"value":45199.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.57 to $13.39. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":38300,"source":{"system":"sec-edgar","filing":"0001584759-26-000017","document":"form4-10022026_091044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000158475926000017/form4-10022026_091044.xml","form_type":"4"}},{"id":4628971,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-02T21:50:48.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":1.6,"value":5600.0,"ownership":{"direct":true},"balance_after":41800,"source":{"system":"sec-edgar","filing":"0001584759-26-000017","document":"form4-10022026_091044.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000158475926000017/form4-10022026_091044.xml","form_type":"4"}},{"id":4627221,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":91900,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":4627220,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":500,"price":13.505,"value":6752.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026."}],"balance_after":69828,"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":4627219,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"sale","planned":true,"acquired":false,"shares":100,"price":13.5,"value":1350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026."}],"balance_after":70328,"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":4627218,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-25T23:59:31.000Z","date":"2026-09-24","kind":"exercise","planned":true,"acquired":true,"shares":600,"price":4.36,"value":2616.0,"ownership":{"direct":true},"balance_after":70428,"source":{"system":"sec-edgar","filing":"0001695028-26-000008","document":"form4-09252026_110926.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1796280/000169502826000008/form4-09252026_110926.xml","form_type":"4"}},{"id":672987,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vested on February 1, 2024, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":120000,"derivative":{"exercise_price":6,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672986,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":false,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":92500,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672985,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"sale","planned":true,"acquired":false,"shares":77000,"price":13.6859,"value":1053814.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 26, 2026."}],"balance_after":69828,"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672984,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":6,"value":150000.0,"ownership":{"direct":true},"balance_after":146828,"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":672983,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-28T16:11:39.000Z","date":"2026-08-26","kind":"exercise","planned":true,"acquired":true,"shares":52000,"price":4.36,"value":226720.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,680 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":121828,"source":{"system":"sec-edgar","filing":"0001695028-26-000006","document":"form4-08282026_080834.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000006/form4-08282026_080834.xml","form_type":"4"}},{"id":702057,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-28T20:15:14.000Z","date":"2026-07-24","kind":"exercise","planned":true,"acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":30200,"derivative":{"exercise_price":1.6,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001584759-26-000015","document":"form4-07282026_080709.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000015/form4-07282026_080709.xml","form_type":"4"}},{"id":702056,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-28T20:15:14.000Z","date":"2026-07-24","kind":"sale","planned":true,"acquired":false,"shares":6100,"price":12.02,"value":73322.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares."}],"balance_after":206672,"source":{"system":"sec-edgar","filing":"0001584759-26-000015","document":"form4-07282026_080709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000015/form4-07282026_080709.xml","form_type":"4"}},{"id":702055,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-28T20:15:14.000Z","date":"2026-07-24","kind":"sale","planned":true,"acquired":false,"shares":7000,"price":12.02,"value":84140.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC."}],"balance_after":38300,"source":{"system":"sec-edgar","filing":"0001584759-26-000015","document":"form4-07282026_080709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000015/form4-07282026_080709.xml","form_type":"4"}},{"id":702054,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-28T20:15:14.000Z","date":"2026-07-24","kind":"exercise","planned":true,"acquired":true,"shares":3500,"price":1.6,"value":5600.0,"ownership":{"direct":true},"balance_after":45300,"source":{"system":"sec-edgar","filing":"0001584759-26-000015","document":"form4-07282026_080709.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000015/form4-07282026_080709.xml","form_type":"4"}},{"id":712462,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T20:35:31.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":300,"price":12,"value":3600.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares."}],"balance_after":212772,"source":{"system":"sec-edgar","filing":"0001584759-26-000012","document":"form4-07082026_080727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000012/form4-07082026_080727.xml","form_type":"4"}},{"id":879695,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-26T21:47:24.000Z","date":"2026-02-24","kind":"exercise","planned":true,"acquired":false,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":144500,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001695028-26-000004","document":"form4-02262026_090218.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000004/form4-02262026_090218.xml","form_type":"4"}},{"id":879694,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:47:24.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":52000,"price":13.5132,"value":702686.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 52,000 shares sold in the price range of $13.50 to $13.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68148,"source":{"system":"sec-edgar","filing":"0001695028-26-000004","document":"form4-02262026_090218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000004/form4-02262026_090218.xml","form_type":"4"}},{"id":879693,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:47:24.000Z","date":"2026-02-24","kind":"exercise","planned":true,"acquired":true,"shares":52000,"price":4.36,"value":226720.0,"ownership":{"direct":true},"balance_after":120148,"source":{"system":"sec-edgar","filing":"0001695028-26-000004","document":"form4-02262026_090218.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000004/form4-02262026_090218.xml","form_type":"4"}},{"id":935021,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T00:19:28.000Z","date":"2026-01-16","kind":"sale","planned":true,"acquired":false,"shares":3200,"price":12.0046,"value":38414.72,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 6,700 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares."}],"balance_after":213072,"source":{"system":"sec-edgar","filing":"0001584759-26-000006","document":"form4-01212026_120124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000006/form4-01212026_120124.xml","form_type":"4"}},{"id":935020,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T00:19:28.000Z","date":"2026-01-16","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":12.0046,"value":42016.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and RAHD Capital, LLC."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 6,700 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":41800,"source":{"system":"sec-edgar","filing":"0001584759-26-000006","document":"form4-01212026_120124.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000006/form4-01212026_120124.xml","form_type":"4"}},{"id":945647,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":25740,"kind":"person","name":"You Angie","position":1,"cik":"0001647664","reported_name":"You Angie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:49:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026."}],"balance_after":40000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001647664-26-000002","document":"form4-01062026_090103.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647664/000164766426000002/form4-01062026_090103.xml","form_type":"4"}},{"id":945782,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:48:01.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026."}],"balance_after":40000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001536368-26-000002","document":"form4-01062026_090157.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000153636826000002/form4-01062026_090157.xml","form_type":"4"}},{"id":945784,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":26666,"kind":"person","name":"Hoerter Steven L.","position":1,"cik":"0001533451","reported_name":"Hoerter Steven L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:47:13.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026."}],"balance_after":40000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001533451-26-000002","document":"form4-01062026_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533451/000153345126000002/form4-01062026_090105.xml","form_type":"4"}},{"id":945710,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:46:07.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026."}],"balance_after":40000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001584759-26-000003","document":"form4-01062026_090104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475926000003/form4-01062026_090104.xml","form_type":"4"}},{"id":946816,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T21:42:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":34500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."}],"balance_after":34500,"derivative":{"underlying":"Common Stock","underlying_shares":34500},"source":{"system":"sec-edgar","filing":"0001695028-26-000002","document":"form4-01062026_090131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000002/form4-01062026_090131.xml","form_type":"4"}},{"id":946815,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:42:35.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":206500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":206500,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":206500},"source":{"system":"sec-edgar","filing":"0001695028-26-000002","document":"form4-01062026_090131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502826000002/form4-01062026_090131.xml","form_type":"4"}},{"id":945709,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T21:41:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."}],"balance_after":35500,"derivative":{"underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001586894-26-000002","document":"form4-01062026_090111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689426000002/form4-01062026_090111.xml","form_type":"4"}},{"id":945708,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:41:15.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":214000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":214000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":214000},"source":{"system":"sec-edgar","filing":"0001586894-26-000002","document":"form4-01062026_090111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689426000002/form4-01062026_090111.xml","form_type":"4"}},{"id":946663,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2026-01-06T21:40:09.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2026, December 15, 2027 and December 15, 2028."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":112500},"source":{"system":"sec-edgar","filing":"0001608936-26-000002","document":"form4-01062026_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893626000002/form4-01062026_090105.xml","form_type":"4"}},{"id":946662,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T21:40:09.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":675000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2027, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":675000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":675000},"source":{"system":"sec-edgar","filing":"0001608936-26-000002","document":"form4-01062026_090105.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893626000002/form4-01062026_090105.xml","form_type":"4"}},{"id":945738,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":62346,"kind":"person","name":"Dier Mardi","position":1,"cik":"0001574591","reported_name":"Dier Mardi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-06T16:44:42.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2026."}],"balance_after":40000,"derivative":{"exercise_price":8.17,"expiration_date":"2036-01-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001574591-26-000002","document":"form4-01062026_090138.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574591/000157459126000002/form4-01062026_090138.xml","form_type":"4"}},{"id":964389,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964388,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964387,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964386,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":10720,"price":9.0605,"value":97128.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 10,720 shares sold in the price range of $9.0449 to $9.1451 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68149,"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":964385,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:21:01.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":29333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,771 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":78869,"source":{"system":"sec-edgar","filing":"0001586894-25-000005","document":"form4-12182025_121256.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000158689425000005/form4-12182025_121256.xml","form_type":"4"}},{"id":965071,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":11333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":22667,"derivative":{"underlying":"Common Stock","underlying_shares":11333},"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965070,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965069,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965068,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":10720,"price":9.0604,"value":97127.488,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 10,720 shares sold in the price range of $9.0396 to $9.1953 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68148,"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":965067,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-12-18T00:19:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":29333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,218 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":78868,"source":{"system":"sec-edgar","filing":"0001695028-25-000008","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000008/form4-12182025_121249.xml","form_type":"4"}},{"id":964984,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":33333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":66667,"derivative":{"underlying":"Common Stock","underlying_shares":33333},"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964983,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":28333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":28334,"derivative":{"underlying":"Common Stock","underlying_shares":28333},"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964982,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":false,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964981,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":33374,"price":9.06,"value":302368.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 33,374 shares sold in the price range of $9.0257 to $9.095 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":581711,"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":964980,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-12-18T00:18:55.000Z","date":"2025-12-15","kind":"exercise","planned":false,"acquired":true,"shares":83666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."}],"balance_after":615085,"source":{"system":"sec-edgar","filing":"0001608936-25-000014","document":"form4-12182025_121249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000014/form4-12182025_121249.xml","form_type":"4"}},{"id":975672,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-09T22:35:02.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2025 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant."}],"balance_after":15600,"derivative":{"exercise_price":7.9,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001536368-25-000006","document":"form4-12092025_101258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000153636825000006/form4-12092025_101258.xml","form_type":"4"}},{"id":975671,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-09T22:35:02.000Z","date":"2025-12-08","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":7.9,"value":79000.0,"ownership":{"direct":true},"balance_after":84200,"source":{"system":"sec-edgar","filing":"0001536368-25-000006","document":"form4-12092025_101258.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000153636825000006/form4-12092025_101258.xml","form_type":"4"}},{"id":978776,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-12-05T22:47:34.000Z","date":"2025-12-04","kind":"exercise","planned":false,"acquired":false,"shares":5534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022."}],"balance_after":0,"derivative":{"exercise_price":3.75,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":5534},"source":{"system":"sec-edgar","filing":"0001536368-25-000004","document":"form4-12052025_101227.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000153636825000004/form4-12052025_101227.xml","form_type":"4"}},{"id":978775,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-05T22:47:34.000Z","date":"2025-12-04","kind":"exercise","planned":false,"acquired":true,"shares":5534,"price":3.75,"value":20752.5,"ownership":{"direct":true},"balance_after":74200,"source":{"system":"sec-edgar","filing":"0001536368-25-000004","document":"form4-12052025_101227.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000153636825000004/form4-12052025_101227.xml","form_type":"4"}},{"id":1021475,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-10-08T21:37:17.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":false,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":196500,"derivative":{"exercise_price":4.36,"exercise_date":"2025-07-20","expiration_date":"2032-07-19","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001695028-25-000004","document":"form4-10082025_091013.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000004/form4-10082025_091013.xml","form_type":"4"}},{"id":1021474,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-08T21:37:17.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":14.5199,"value":159718.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 24, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 11,000 shares sold in the price range of $14.50 to $14.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":48317,"source":{"system":"sec-edgar","filing":"0001695028-25-000004","document":"form4-10082025_091013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000004/form4-10082025_091013.xml","form_type":"4"}},{"id":1021473,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-08T21:37:17.000Z","date":"2025-10-06","kind":"exercise","planned":true,"acquired":true,"shares":11000,"price":4.36,"value":47960.0,"ownership":{"direct":true},"balance_after":59317,"source":{"system":"sec-edgar","filing":"0001695028-25-000004","document":"form4-10082025_091013.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000169502825000004/form4-10082025_091013.xml","form_type":"4"}},{"id":1021409,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-10-08T21:35:33.000Z","date":"2025-10-06","kind":"sale","planned":true,"acquired":false,"shares":37461,"price":12.32,"value":461519.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 37,461 shares sold in the price range of $12.07 to $12.59 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":531419,"source":{"system":"sec-edgar","filing":"0001608936-25-000010","document":"form4-10082025_091029.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000010/form4-10082025_091029.xml","form_type":"4"}},{"id":1024075,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-03T23:18:01.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":1447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":52253,"derivative":{"exercise_price":3.75,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":1447},"source":{"system":"sec-edgar","filing":"0001584759-25-000004","document":"form4-10032025_111055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475925000004/form4-10032025_111055.xml","form_type":"4"}},{"id":1024074,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-03T23:18:01.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":18125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.6,"expiration_date":"2028-06-28","underlying":"Common Stock","underlying_shares":18125},"source":{"system":"sec-edgar","filing":"0001584759-25-000004","document":"form4-10032025_111055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475925000004/form4-10032025_111055.xml","form_type":"4"}},{"id":1024073,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-10-03T23:18:01.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":13228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":33700,"derivative":{"exercise_price":1.6,"expiration_date":"2028-02-28","underlying":"Common Stock","underlying_shares":13228},"source":{"system":"sec-edgar","filing":"0001584759-25-000004","document":"form4-10032025_111055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475925000004/form4-10032025_111055.xml","form_type":"4"}},{"id":1024072,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T23:18:01.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":1447,"price":3.75,"value":5426.25,"ownership":{"direct":true},"balance_after":45300,"source":{"system":"sec-edgar","filing":"0001584759-25-000004","document":"form4-10032025_111055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475925000004/form4-10032025_111055.xml","form_type":"4"}},{"id":1024071,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T23:18:01.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":31353,"price":1.6,"value":50164.8,"ownership":{"direct":true},"balance_after":43853,"source":{"system":"sec-edgar","filing":"0001584759-25-000004","document":"form4-10032025_111055.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000158475925000004/form4-10032025_111055.xml","form_type":"4"}},{"id":1027169,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-10-02T23:18:37.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":53001,"price":12.0527,"value":638805.1527,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 53,001 shares sold in the price range of $12.00 to $12.13 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":568880,"source":{"system":"sec-edgar","filing":"0001608936-25-000008","document":"form4-10022025_111028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000008/form4-10022025_111028.xml","form_type":"4"}},{"id":1027168,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-10-02T23:18:37.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":34538,"price":12.0085,"value":414749.573,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 34,538 shares sold in the price range of $12.00 to $12.03 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":621881,"source":{"system":"sec-edgar","filing":"0001608936-25-000008","document":"form4-10022025_111028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000008/form4-10022025_111028.xml","form_type":"4"}},{"id":1033016,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2025-09-24T20:30:20.000Z","date":"2025-09-22","kind":"sale","planned":true,"acquired":false,"shares":125000,"price":10.7995,"value":1349937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 21, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 125,000 shares sold in the price range of $10.57 to $10.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,771 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person also holds restricted stock units (RSUs) representing a contingent right to receive 178,667 shares of ORIC Pharmaceuticals, Inc. Common Stock and stock options to purchase 3,378,000 shares of ORIC Pharmaceuticals, Inc. Common Stock, which were previously reported on Table II and are not included in this number."}],"balance_after":656419,"source":{"system":"sec-edgar","filing":"0001608936-25-000006","document":"form4-09242025_080916.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000160893625000006/form4-09242025_080916.xml","form_type":"4"}},{"id":1095225,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-02T20:07:16.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":10.0486,"value":200972.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 20,000 shares sold in the price range of $10.00 to $10.135 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":48317,"source":{"system":"sec-edgar","filing":"0001415889-25-019000","document":"form4-07022025_080708.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925019000/form4-07022025_080708.xml","form_type":"4"}},{"id":1102658,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-24T22:33:12.000Z","date":"2025-06-24","kind":"sale","planned":true,"acquired":false,"shares":32466,"price":10.5045,"value":341039.097,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 32,466 shares sold in the price range of $10.34 to $10.80 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":68317,"source":{"system":"sec-edgar","filing":"0001415889-25-018128","document":"form4-06242025_100608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925018128/form4-06242025_100608.xml","form_type":"4"}},{"id":1102657,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-24T22:33:12.000Z","date":"2025-06-23","kind":"sale","planned":true,"acquired":false,"shares":450,"price":10.01,"value":4504.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":100783,"source":{"system":"sec-edgar","filing":"0001415889-25-018128","document":"form4-06242025_100608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925018128/form4-06242025_100608.xml","form_type":"4"}},{"id":1102656,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-24T22:33:12.000Z","date":"2025-06-23","kind":"sale","planned":true,"acquired":false,"shares":584,"price":10,"value":5840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":101233,"source":{"system":"sec-edgar","filing":"0001415889-25-018128","document":"form4-06242025_100608.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925018128/form4-06242025_100608.xml","form_type":"4"}},{"id":1103432,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":25740,"kind":"person","name":"You Angie","position":1,"cik":"0001647664","reported_name":"You Angie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T00:05:17.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":1403,"price":9.43,"value":13230.29,"ownership":{"direct":true},"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001415889-25-018014","document":"form4-06242025_120613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1647664/000141588925018014/form4-06242025_120613.xml","form_type":"4"}},{"id":1103431,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":25740,"kind":"person","name":"You Angie","position":1,"cik":"0001647664","reported_name":"You Angie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T00:05:17.000Z","date":"2025-06-20","kind":"purchase","planned":false,"acquired":true,"shares":26597,"price":9.3871,"value":249668.6987,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average share price of an aggregate total of 26,597 shares purchased in the price range of $9.14 to $9.50 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":26597,"source":{"system":"sec-edgar","filing":"0001415889-25-018014","document":"form4-06242025_120613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647664/000141588925018014/form4-06242025_120613.xml","form_type":"4"}},{"id":1111672,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-13T23:38:23.000Z","date":"2025-06-12","kind":"sale","planned":true,"acquired":false,"shares":300,"price":10,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":101817,"source":{"system":"sec-edgar","filing":"0001415889-25-017325","document":"form4-06132025_110620.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925017325/form4-06132025_110620.xml","form_type":"4"}},{"id":1114953,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:37:51.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":1700,"price":10.01,"value":17017.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":102117,"source":{"system":"sec-edgar","filing":"0001415889-25-016739","document":"form4-06112025_100647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016739/form4-06112025_100647.xml","form_type":"4"}},{"id":1114952,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:37:51.000Z","date":"2025-06-11","kind":"sale","planned":true,"acquired":false,"shares":1276,"price":10,"value":12760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":103817,"source":{"system":"sec-edgar","filing":"0001415889-25-016739","document":"form4-06112025_100647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016739/form4-06112025_100647.xml","form_type":"4"}},{"id":1114951,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-11T22:37:51.000Z","date":"2025-06-10","kind":"sale","planned":true,"acquired":false,"shares":324,"price":10,"value":3240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,553 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":105093,"source":{"system":"sec-edgar","filing":"0001415889-25-016739","document":"form4-06112025_100647.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016739/form4-06112025_100647.xml","form_type":"4"}},{"id":1117902,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T00:18:27.000Z","date":"2025-06-09","kind":"sale","planned":true,"acquired":false,"shares":300,"price":10,"value":3000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":103864,"source":{"system":"sec-edgar","filing":"0001415889-25-016386","document":"form4-06102025_120617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016386/form4-06102025_120617.xml","form_type":"4"}},{"id":1117901,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-10T00:18:27.000Z","date":"2025-06-06","kind":"sale","planned":true,"acquired":false,"shares":2600,"price":10.0082,"value":26021.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 2,600 shares sold in the price range of $10.00 to $10.04 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":104164,"source":{"system":"sec-edgar","filing":"0001415889-25-016386","document":"form4-06102025_120617.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925016386/form4-06102025_120617.xml","form_type":"4"}},{"id":1226757,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T22:27:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.33,"exercise_date":"2024-06-11","expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":20500},"source":{"system":"sec-edgar","filing":"0001415889-25-006616","document":"form4-03042025_100357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000141588925006616/form4-03042025_100357.xml","form_type":"4"}},{"id":1226756,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T22:27:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":false,"shares":27666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(A) 20,500 of the shares subject to the option shall vest on the earlier of (i) June 17, 2023 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant, and (B) one thirty-sixth (1/36th) of the remaining 33,200 shares subject to the option shall vest on each monthly anniversary of June 17, 2022."}],"balance_after":5534,"derivative":{"exercise_price":3.75,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":27666},"source":{"system":"sec-edgar","filing":"0001415889-25-006616","document":"form4-03042025_100357.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000141588925006616/form4-03042025_100357.xml","form_type":"4"}},{"id":1226755,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-04T22:27:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":20500,"price":6.33,"value":129765.0,"ownership":{"direct":true},"balance_after":68666,"source":{"system":"sec-edgar","filing":"0001415889-25-006616","document":"form4-03042025_100357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000141588925006616/form4-03042025_100357.xml","form_type":"4"}},{"id":1226754,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-04T22:27:04.000Z","date":"2025-03-03","kind":"exercise","planned":false,"acquired":true,"shares":27666,"price":3.75,"value":103747.5,"ownership":{"direct":true},"balance_after":48166,"source":{"system":"sec-edgar","filing":"0001415889-25-006616","document":"form4-03042025_100357.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000141588925006616/form4-03042025_100357.xml","form_type":"4"}},{"id":1309683,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":25740,"kind":"person","name":"You Angie","position":1,"cik":"0001647664","reported_name":"You Angie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T21:47:57.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-000795","document":"form4-01062025_090153.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1647664/000141588925000795/form4-01062025_090153.xml","form_type":"4"}},{"id":1309793,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":31442,"kind":"person","name":"Kunkel Lori Anne","position":1,"cik":"0001536368","reported_name":"Kunkel Lori Anne","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T21:46:39.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-000792","document":"form4-01062025_090135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1536368/000141588925000792/form4-01062025_090135.xml","form_type":"4"}},{"id":1309794,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":26666,"kind":"person","name":"Hoerter Steven L.","position":1,"cik":"0001533451","reported_name":"Hoerter Steven L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T21:45:43.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-000788","document":"form4-01062025_090139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1533451/000141588925000788/form4-01062025_090139.xml","form_type":"4"}},{"id":1309734,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":28195,"kind":"person","name":"Heyman Richard A.","position":1,"cik":"0001584759","reported_name":"Heyman Richard A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T21:44:52.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-000785","document":"form4-01062025_090141.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1584759/000141588925000785/form4-01062025_090141.xml","form_type":"4"}},{"id":1309739,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":62346,"kind":"person","name":"Dier Mardi","position":1,"cik":"0001574591","reported_name":"Dier Mardi","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T16:43:37.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/12th of the shares subject to the option shall vest on each one month anniversary of January 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-25-000782","document":"form4-01062025_090133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1574591/000141588925000782/form4-01062025_090133.xml","form_type":"4"}},{"id":1313486,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-03T22:42:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-25-000602","document":"form4-01032025_100144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588925000602/form4-01032025_100144.xml","form_type":"4"}},{"id":1313485,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:42:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":202500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":202500,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":202500},"source":{"system":"sec-edgar","filing":"0001415889-25-000602","document":"form4-01032025_100144.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588925000602/form4-01032025_100144.xml","form_type":"4"}},{"id":1314853,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-01-03T22:41:54.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":34000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":34000,"derivative":{"underlying":"Common Stock","underlying_shares":34000},"source":{"system":"sec-edgar","filing":"0001415889-25-000601","document":"form4-01032025_100150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925000601/form4-01032025_100150.xml","form_type":"4"}},{"id":1314852,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:41:54.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":202500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":202500,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":202500},"source":{"system":"sec-edgar","filing":"0001415889-25-000601","document":"form4-01032025_100150.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588925000601/form4-01032025_100150.xml","form_type":"4"}},{"id":1314679,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Restricted Stock Unit","published_at":"2025-01-03T22:41:01.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"1/3rd of the RSUs subject to the award shall vest on each of December 15, 2025, December 15, 2026 and December 15, 2027."}],"balance_after":100000,"derivative":{"underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-000600","document":"form4-01032025_100156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588925000600/form4-01032025_100156.xml","form_type":"4"}},{"id":1314678,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":36806,"kind":"person","name":"Chacko Jacob","position":1,"cik":"0001608936","reported_name":"Chacko Jacob","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T22:41:01.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on January 2, 2026, and 1/36th of the remaining shares subject to the option shall vest each month thereafter."}],"balance_after":600000,"derivative":{"exercise_price":8.26,"expiration_date":"2035-01-01","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001415889-25-000600","document":"form4-01032025_100156.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608936/000141588925000600/form4-01032025_100156.xml","form_type":"4"}},{"id":1328788,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328787,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328786,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6042},"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328785,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-16","kind":"sale","planned":false,"acquired":false,"shares":8851,"price":8.2813,"value":73297.7863,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents the number of shares sold to cover the tax withholding obligations in connection with the vesting of RSUs and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average share price of an aggregate total of 8,851 shares sold in the price range of $8.28 to $8.41 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":106764,"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328784,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":18726,"kind":"person","name":"Piscitelli Dominic","position":1,"cik":"0001695028","reported_name":"Piscitelli Dominic","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-12-17T22:23:36.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":true,"shares":24042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 7,764 shares of Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan."}],"balance_after":115615,"source":{"system":"sec-edgar","filing":"0001415889-24-029634","document":"form4-12172024_101232.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1695028/000141588924029634/form4-12172024_101232.xml","form_type":"4"}},{"id":1328085,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2024, December 15, 2025 and December 15, 2026."}],"balance_after":20000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}},{"id":1328084,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2023, December 15, 2024 and December 15, 2025."}],"balance_after":8000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}},{"id":1328083,"issuer":{"id":4765,"kind":"organization","name":"Oric Pharmaceuticals, Inc.","symbol":"ORIC"},"owners":[{"id":34832,"kind":"person","name":"Multani Pratik S","position":1,"cik":"0001586894","reported_name":"Multani Pratik S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-12-17T22:22:34.000Z","date":"2024-12-15","kind":"exercise","planned":false,"acquired":false,"shares":6042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of ORIC Pharmaceuticals, Inc. (the \"Issuer\") Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs subject to the award shall vest on each of December 15, 2022, December 15, 2023 and December 15, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6042},"source":{"system":"sec-edgar","filing":"0001415889-24-029633","document":"form4-12172024_101230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1586894/000141588924029633/form4-12172024_101230.xml","form_type":"4"}}],"next_cursor":"2024-12-17T22:22:34.000000Z,1328083"}